Andrew D. Schiermeier
2018
In 2018, Andrew D. Schiermeier earned a total compensation of $2.9M as Executive Vice President, Development and Corporate Strategy at Intellia Therapeutics.
Compensation breakdown
| Bonus | $182,600 |
|---|---|
| Option Awards | $2,028,554 |
| Salary | $408,934 |
| Stock Awards | $295,550 |
| Other | $9,668 |
| Total | $2,925,306 |
Schiermeier received $2M in option awards, accounting for 69% of the total pay in 2018.
Schiermeier also received $182.6K in bonus, $408.9K in salary, $295.6K in stock awards and $9.7K in other compensation.
Rankings
In 2018, Andrew D. Schiermeier's compensation ranked 3,971st out of 14,244 executives tracked by ExecPay. In other words, Schiermeier earned more than 72.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,971 out of 14,244 | 72nd |
Division Manufacturing | 1,461 out of 5,765 | 75th |
Major group Chemicals And Allied Products | 519 out of 2,128 | 76th |
Industry group Drugs | 436 out of 1,817 | 76th |
Industry In Vitro and In Vivo Diagnostic Substances | 6 out of 72 | 92nd |
Source: SEC filing on April 16, 2019.
Schiermeier's colleagues
We found four more compensation records of executives who worked with Andrew D. Schiermeier at Intellia Therapeutics in 2018.